SBI JI Innovation Fund is a biopharma-focused venture capital fund. SBI JI was formed in early 2017 as a partnership between SBI Holdings, a Japanese-based financial services group; and Vertex, an Israeli venture capital investment firm investing in promising Israeli early-stage companies, with over $900 million under management. SBI JI cherry-picks Israeli or Israel-related venture-backed biopharma companies across different developmental stages. SBI JI is actively seeking companies that meet the following criteria: companies with state-of-the-art scientific foundations backed by a strong IP protection; companies that have already attracted investment from world-class investors; companies that have indications of inadequate or nonexistent therapies; companies managed by industry veterans, from executives to scientists; and companies with a rich therapeutic pipeline to follow the lead indication.
| Name | SBI JI Innovation Fund |
|---|---|
| Slug | sbi-ji-innovation-fund |
| Type / kind | vc |
| Crunchbase ID | sbi-japan-israel-innovation-fund |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJvW_-EKDA |
| Status | active |
|---|---|
| Last update | 2026-05-17 |
| HQ country | Israel |
|---|---|
| HQ country code | IL |
| HQ city | Tel Aviv-Yafo |
| HQ address | HaArba'a Street 28, Tel Aviv-Yafo, Israel |
| Website | http://sbi-ji.co.il/ |
|---|
| Total raised | — |
|---|
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}